Clinical Trials Logo
  1. Home
  2. Alström Syndrome
  3. NCT04461444

COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Monocentric Interventional Study — COBBALT  

Bardet-Biedl Syndrome Clinical Trial

Official title:
COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Etude Interventionnelle Monocentrique

Clinical Trial Summary

ALMS and BBS syndromes are rare diseases with overlapping features of multiple sensory and metabolic impairments, including diabetes mellitus. There are to date no specific treatments available and limited information on the natural history of the diseases. the investigators aim to establish a French cohort for these diseases to improve patient care and assess the effect of actual therapies on quality of life. The purpose of this study is to establish a cohort of Bardet-Bield syndrome (BBS) and ALström syndrome (ALMS) patients in order to formalize and address questions concerning the in-depth natural clinical and biological history of the disease on the long term for a given patient, establish the impact on the quality of life of various clinical manifestations

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04461444
Study type Interventional
Source University Hospital, Strasbourg, France
Contact Hélène DOLFFUS
Phone +33.3.69.55.19.55
Email helene.dollfus@chru-strasbourg.fr
Status Recruiting
Phase N/A
Start date June 16, 2020
Completion date February 2035
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04874909 - Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) N/A
Recruiting NCT02329210 - Clinical Registry Investigating Bardet-Biedl Syndrome
Recruiting NCT02435940 - Inherited Retinal Degenerative Disease Registry
Completed NCT00213811 - Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults N/A
Recruiting NCT06239064 - Early Genetic Identification of Obesity
Terminated NCT00078091 - Genetics and Clinical Characteristics of Bardet-Biedl Syndrome
Completed NCT04966741 - Setmelanotide in Pediatric Patients With Rare Genetic Diseases of Obesity Phase 3
Enrolling by invitation NCT05400278 - Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl Syndrome
Completed NCT05194124 - Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Patients With Specific Gene Defects in the MC4R Pathway Phase 3
Withdrawn NCT03490019 - Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement Phase 2